These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38773596)

  • 1. Natural L-type calcium channels antagonists from Chinese medicine.
    Xu F; Cai W; Liu B; Qiu Z; Zhang X
    Chin Med; 2024 May; 19(1):72. PubMed ID: 38773596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in L-Type Calcium Channel Structures, Functions and Molecular Modeling.
    Xu L; Sun L; Xie L; Mou S; Zhang D; Zhu J; Xu P
    Curr Med Chem; 2021; 28(3):514-524. PubMed ID: 32664834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic interplay of excitatory and inhibitory coupling modes of neuronal L-type calcium channels.
    Geier P; Lagler M; Boehm S; Kubista H
    Am J Physiol Cell Physiol; 2011 Apr; 300(4):C937-49. PubMed ID: 21228322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different subcellular populations of L-type Ca2+ channels exhibit unique regulation and functional roles in cardiomyocytes.
    Best JM; Kamp TJ
    J Mol Cell Cardiol; 2012 Feb; 52(2):376-87. PubMed ID: 21888911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoenviroments of the β-Subunit of L-Type Voltage-Gated Calcium Channels in Adult Cardiomyocytes.
    Cruz-Garcia Y; Barkovits K; Kohlhaas M; Pickel S; Gulentz M; Heindl C; Pfeiffer K; Eder-Negrin P; Maack C; Marcus K; Kuhn M; Miranda-Laferte E
    Front Cell Dev Biol; 2021; 9():724778. PubMed ID: 35047492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the Joining Region in Junctophilin-2 With the L-Type Ca
    Gross P; Johnson J; Romero CM; Eaton DM; Poulet C; Sanchez-Alonso J; Lucarelli C; Ross J; Gibb AA; Garbincius JF; Lambert J; Varol E; Yang Y; Wallner M; Feldsott EA; Kubo H; Berretta RM; Yu D; Rizzo V; Elrod J; Sabri A; Gorelik J; Chen X; Houser SR
    Circ Res; 2021 Jan; 128(1):92-114. PubMed ID: 33092464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Affinity of Isradipine for L-Type Ca
    Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
    J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-ionotropic voltage-gated calcium channel signaling.
    Trus M; Atlas D
    Channels (Austin); 2024 Dec; 18(1):2341077. PubMed ID: 38601983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of L-type calcium channels in Alzheimer's disease: A potential therapeutic target.
    Crossley CA; Rajani V; Yuan Q
    Comput Struct Biotechnol J; 2023; 21():11-20. PubMed ID: 36514335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDIMP, a novel cardiac Ca(2+) channel blocker with atrial selectivity.
    Santamaria-Herrera MA; Ríos-Pérez EB; de la Rosa JA; García-Castañeda M; Osornio-Garduño DS; Ramos-Mondragón R; Mancilla-Percino T; Avila G
    Eur J Pharmacol; 2016 Jun; 781():218-28. PubMed ID: 27089820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-type calcium channel targeting and local signalling in cardiac myocytes.
    Shaw RM; Colecraft HM
    Cardiovasc Res; 2013 May; 98(2):177-86. PubMed ID: 23417040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose combination of Rho kinase and L-type Ca(2+) channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction.
    Porras-González C; González-Rodríguez P; Calderón-Sánchez E; López-Barneo J; Ureña J
    Eur J Pharmacol; 2014 Jun; 732():130-8. PubMed ID: 24680953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ Channels in Anterior Pituitary Somatotrophs: A Therapeutic Perspective.
    Nussinovitch I
    Endocrinology; 2018 Dec; 159(12):4043-4055. PubMed ID: 30395240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A caveolae-targeted L-type Ca²+ channel antagonist inhibits hypertrophic signaling without reducing cardiac contractility.
    Makarewich CA; Correll RN; Gao H; Zhang H; Yang B; Berretta RM; Rizzo V; Molkentin JD; Houser SR
    Circ Res; 2012 Mar; 110(5):669-74. PubMed ID: 22302787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for cooperative gating of L-type Ca2+ channels and its effects on cardiac alternans dynamics.
    Sato D; Dixon RE; Santana LF; Navedo MF
    PLoS Comput Biol; 2018 Jan; 14(1):e1005906. PubMed ID: 29338006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raised activity of L-type calcium channels renders neurons prone to form paroxysmal depolarization shifts.
    Rubi L; Schandl U; Lagler M; Geier P; Spies D; Gupta KD; Boehm S; Kubista H
    Neuromolecular Med; 2013 Sep; 15(3):476-92. PubMed ID: 23695859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering of Ca
    Yang Q; Perfitt TL; Quay J; Hu L; Lawson-Qureshi D; Colbran RJ
    J Neurochem; 2023 Oct; 167(1):16-37. PubMed ID: 37392026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-type Ca2+ channels: a new player in the regulation of Ca2+ signaling, cell activation and cell survival in immune cells.
    Suzuki Y; Inoue T; Ra C
    Mol Immunol; 2010 Jan; 47(4):640-8. PubMed ID: 19926136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutively active L-type Ca2+ channels.
    Navedo MF; Amberg GC; Votaw VS; Santana LF
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11112-7. PubMed ID: 16040810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Store-operated calcium entry is required for sustained contraction and Ca
    Chen J; Sanderson MJ
    J Physiol; 2017 May; 595(10):3203-3218. PubMed ID: 27396568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.